Prognostic Effect Of Comorbidities Among Patients With Chronic Myeloid Leukemia In Chronic Phase Treated With Second Generation Tyrosine Kinase Inhibitors A Five Year Retrospective Study | Philippine College of Hematology and Transfusion Medicine

PHILIPPINE COLLEGE OF HEMATOLOGY AND TRANSFUSION MEDICINE

Prognostic Effect of Comorbidities Among Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Second Generation Tyrosine Kinase Inhibitors: A Five-Year Retrospective Study Venessa S. Ediza MD¹ , Anne Kristine H. Quero-Taggaoa,MD² Contact: vanediza08@gmail.com

Graft Versus Host Disease, A Rare Side Effect Of Covid 19 Mrna Vaccines In Post Allogeneic Hematopoietic Stem Cell Transplant Patients : A Case Series
Mary Anne Lorraine Kua, MD & Internal Medicine-Hematology Fellow & Francisco Vicente Lopez, M

Clinical Profile And Management Outcomes Of Adult Filipino Patients With Hemophagocytic Lymphohistiocytosis In A Tertiary Hospital
Eunice P. Empeño, MD